1141 – 1150 of 1751
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Evaluation of potential biomarkers for the discrimination of bacterial and viral infections
(
- Contribution to journal › Article
-
Mark
Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes.
(
- Contribution to journal › Article
-
Mark
Activation of the contact system at the surface of Fusobacterium necrophorum: a possible virulence mechanism in Lemierre's syndrome.
(
- Contribution to journal › Article
-
Mark
Cysteine proteinase SpeB from Streptococcus pyogenes - a potent modifier of immunologically important host and bacterial proteins
(
- Contribution to journal › Scientific review
-
Mark
Enhanced Activity of Transforming Growth Factor beta 1 (TGF-beta 1) Bound to Cartilage Oligomeric Matrix Protein
(
- Contribution to journal › Article
-
Mark
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
(
- Contribution to journal › Article
-
Mark
Executive Summary: International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
(
- Contribution to journal › Article
-
Mark
Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal {beta} Protein.
(
- Contribution to journal › Article
-
Mark
The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis
(
- Contribution to journal › Article
-
Mark
Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naive HIV-1 infected patients
(
- Contribution to journal › Article